Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase
✍ Scribed by T.M. SANKARY; G. YANG; J.M. ROMEO; P.P. ULRICH; M.P. BUSCH; B.D. RAWAL; G.N. VYAS
- Book ID
- 114439859
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 437 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A multi‐targeted “hemi‐nested” PCR (M‐PCR) assay in which the primer pairs derived from the 5′ non‐coding (5′NC) and the nonstructural protein 3 (NS3) regions of HCV genome were concurrently used for amplification in order to compare the sensitivity and specificity of polymerase chain r
## Abstract Hepatitis C virus (HCV) represents a major cause of posttransfusion hepatitis worldwide. Post‐transfusion hepatitis associated with hepatitis B virus (HBV) continues to occur. HBsAg‐negative donor sera from the Rhode Island Blood Center between 1987 and 1988 were screened using more sen
## Abstract The low specificity of screening ELISAs for antibodies to hepatitis C virus in blood donors has called for confirmatory tests. Two types of supplementary antibody assays are available, recombinant immunoblot assays (RIBA‐1 and RIBA‐2) and an antibody consumption test referred to as a ne
## Abstract The mean prevalence of anti‐hepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired non‐A, non‐B (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem